Tradestie Institutional Equity Comparison Engine

XLII vs XLVI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XLVI Overall Edge

XLVI Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Health Care Select Sector SPDR Premium Income Fund (XLVI) driven by superior Momentum & Technical. Fundamentally, XLII trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XLVI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XLII sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XLVI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
XLII N/M vs XLVI N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner XLVI
1Y -4.5% vs +3.9% ยท 52W Pos 16% vs 89%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
XLII NYSE Arca
The Industrial Select Sector SPDR Premium Income Fund
Institutional Equity
$23.69
-1.55% 1D
Market Cap N/A
1M Return -1.21%
1Y Return -4.55%
Forward P/E N/M
Unified AI Score
50.0 / 100 HOLD
Tech 48.0 Fund 64.0 Flow 50.0 Mom 64.0
XLVI NYSE Arca
The Health Care Select Sector SPDR Premium Income Fund
Institutional Equity
$27.33
-0.47% 1D
Market Cap N/A
1M Return +1.52%
1Y Return +3.92%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XLII -4.55% XLVI +3.92% Spread: +7.29 pp (XLVI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XLII TTM Op. Margin: N/A XLVI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XLII vs XLVI. Trailing 12-month operating profitability (XLII N/A vs XLVI N/A) and valuation multiples (XLII N/M vs XLVI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XLII (0) vs XLVI (3)
Institutional Metric XLII XLVI Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 16% ($23โ€“$27) 89% ($24โ€“$28) Stronger Trend XLVI
Beta / 30D Volatility Risk Regime 0.76ฮฒ ยท 20% Vol 0.20ฮฒ ยท 9% Vol Lower Realized Risk XLVI
Unified Institutional Score Composite Signal 50.0 / 100 (HOLD) 51.1 / 100 (HOLD) Higher Composite XLVI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XLII vs XLVI Buy Guide
XLII UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XLII Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XLVI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XLVI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XLII nor XLVI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.